APRINOIA Therapeutics is based in Boston, Massachusetts. It has raised $11M in total funding. Latest round: Series B.
APRINOIA Therapeutics is based in Boston, Massachusetts. APRINOIA Therapeutics has raised $11M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in January 2018. The round record for APRINOIA Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include KTB Network, DCI Partners, ShangPharma Investment Group, TaiAn Technologies, Daiwa Corporate Investment, Kevin KUK Hyun Kyung and 1 others. 7 distinct backers are named across the disclosed rounds.
Totals shown for APRINOIA Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026